DCIR Inhibitors
DCIR inhibitors belong to a class of chemical compounds designed to target and modulate the activity of Dendritic Cell Immunoreceptor (DCIR), a transmembrane protein expressed predominantly on dendritic cells, a crucial component of the immune system. DCIR is recognized for its involvement in regulating immune responses and maintaining immune homeostasis. As a C-type lectin receptor, DCIR plays a pivotal role in antigen recognition and presentation, contributing to the orchestration of both innate and adaptive immune responses. The development of DCIR inhibitors stems from a keen interest in elucidating the molecular mechanisms underlying immune regulation, with a focus on modulating dendritic cell function.
DCIR inhibitors are meticulously designed compounds that interact with specific binding sites on the DCIR protein, thereby influencing its activity. By selectively targeting DCIR, these inhibitors aim to provide researchers with valuable tools to probe the intricate signaling pathways associated with dendritic cell function. Understanding the precise modulation of DCIR activity may offer insights into immune system regulation, potentially paving the way for novel strategies in immunomodulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate immune responses, possibly affecting DCIR by altering dendritic cell function. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is known to influence immune signaling pathways that could intersect with DCIR-mediated processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine affects endosomal/lysosomal pH, which might alter DCIR antigen processing and presentation. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
These inhibitors can affect signaling pathways upstream or downstream of DCIR, altering its activation state. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
By inhibiting NF-κB, these compounds may alter the expression of genes regulated by DCIR signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K pathway is crucial for several immune cell functions, potentially affecting DCIR signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting MAPK, these compounds could affect cellular responses mediated by DCIR. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
This immunosuppressant can modulate immune cell activity, thereby potentially affecting DCIR-mediated processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can have downstream effects on DCIR-related signaling pathways. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
These compounds can suppress immune responses, possibly influencing DCIR function. | ||||||